Pharma GP

GP Pharm is a Spanish biopharmaceutical company specializing in the development, manufacturing, and marketing of innovative injectable products using advanced drug delivery systems. Founded in 2000 and headquartered in the Barcelona area, the company focuses on oncology and urology, leveraging its proprietary microsphere and liposome technological platforms to create sustained-release formulations. GP Pharm's commercial portfolio includes products like Lutrate (leuprorelin) for prostate cancer and Acore (octreotide) for acromegaly. In addition to its own product pipeline, the company operates as a specialized Contract Development and Manufacturing Organization (CDMO), providing complex injectable formulation and manufacturing services to global pharmaceutical partners.